1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street
With the recent market sell-off, now is potentially the time for investors to find their next big winner. After all, if one had invested in stocks during the bear markets of late 2018, the Covid drawdown of 2020, or the interest rate driven drawdown of 2022, you likely would have made out quite well.Coming off a late-year slowdown and short-seller attack, this disruptive medical tech stock is currently over 60% off its all-time highs set just last year. But with recent better-than-expected Q4 results and a thorough refuting of the short case, is now the time to pick up shares of this turnaround stock? TransMedics Group (NASDAQ: TMDX) was founded in 1998, but has only been a public company since 2019. Its novel organ care system (OCS) is a new and unique way of preserving organs for transport. As opposed to freezing, TransMedics' OCS keeps organs "alive" through perfusion, a method of circulating warm, oxygenated and nutrient-rich blood through the organ during transport. This new method has been shown to improve the percentage of donated organs that can be utilized, with less permanent damage, and it also allows medical technicians to monitor the health of the organ during transport. Continue reading
With the recent market sell-off, now is potentially the time for investors to find their next big winner. After all, if one had invested in stocks during the bear markets of late 2018, the Covid drawdown of 2020, or the interest rate driven drawdown of 2022, you likely would have made out quite well.
Coming off a late-year slowdown and short-seller attack, this disruptive medical tech stock is currently over 60% off its all-time highs set just last year. But with recent better-than-expected Q4 results and a thorough refuting of the short case, is now the time to pick up shares of this turnaround stock?
TransMedics Group (NASDAQ: TMDX) was founded in 1998, but has only been a public company since 2019. Its novel organ care system (OCS) is a new and unique way of preserving organs for transport. As opposed to freezing, TransMedics' OCS keeps organs "alive" through perfusion, a method of circulating warm, oxygenated and nutrient-rich blood through the organ during transport. This new method has been shown to improve the percentage of donated organs that can be utilized, with less permanent damage, and it also allows medical technicians to monitor the health of the organ during transport.
